|SEQ_NO||1||Date of announcement||2021/02/09||Time of announcement||13:14:08|
|Subject||Announcement of TTY Biopharm's unaudited income information in January 2021|
|Date of events||2021/02/09||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/02/09
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $382,907 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $112,249 thousands, and a consolidated income before tax of $119,719 thousands in January 2021; net income attributed to stockholders of the company was $95,849 thousands; EPS is $0.39.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.